Jakub Rafał Rzepka

Mr. Jakub Rafał Rzepka


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
BPBanach Paulina
Banach Paulina
JKJustyna Kuczkowska
Justyna Kuczkowska
YAYulia Areshchanka
Yulia Areshchanka
WBWeronika Banach
Weronika Banach
JRJakub Rafał Rzepka
Jakub Rafał Rzepka
RRRafał Rzepka
Rafał Rzepka
Background/Objectives: This article presents the case of a 31-year-old primigravida who experienced acute liver failure in the 23rd week of pregnancy, along with a review of the literature on this rare condition during pregnancy. The purpose of this publication is to highlight the diagnostic and therapeutic challenges associated with acute liver failure in pregnant women. Methods: The patient presented with jaundice, pruritus, and dark-colored urine. Laboratory tests revealed a significant increase in aminotransferase, bilirubin, and bile acid levels, suggesting liver problems; however, due to the patient’s rapidly deteriorating condition and test results, autoimmune hepatitis was considered. Viral infections and other causes of liver damage were excluded. No clear diagnosis was established. The patient was administered ursodeoxycholic acid and due to her worsening condition, a cesarean section was performed at 23 weeks of gestation. After delivery, the patient’s condition improved, although she did experience cardiac arrest during hospitalization. The patient was discharged with a diagnosis of acute liver failure in the course of an overlap syndrome of autoimmune hepatitis and primary cholangitis or intrahepatic cholestasis of pregnancy. No abnormalities were noted during a follow-up visit 6 weeks after delivery. Despite a detailed case analysis, a final diagnosis was not established, which complicates planning for future pregnancies. Discussion: Several liver conditions can occur during pregnancy, including intrahepatic cholestasis of pregnancy, primary biliary cholangitis, and autoimmune hepatitis. Diagnosing these conditions can be challenging due to overlapping symptoms and metabolic and immunological adaptations during pregnancy that can affect the course of liver diseases. Rapid intervention is crucial to protect the health of both the mother and the fetus. Conclusions: In summary, this article aims to increase awareness of the complexities surrounding acute liver failure during pregnancy, highlighting the diagnostic challenges and importance of prompt medical intervention for the well-being of both the mother and the child. This paper aims to provide a comprehensive overview of the complexities surrounding acute liver failure during pregnancy, aiming to improve the understanding, diagnosis, and management of this condition.

Verified
Journal Article
Open access
PDF file
JLJagoda Langiewicz
Jagoda Langiewicz
OWOlga Wiśniewska
Olga Wiśniewska
JRJakub Rafał Rzepka
Jakub Rafał Rzepka
MMMichał Michalczyk
Michał Michalczyk
MMMarzena Michalak-Kloc
Marzena Michalak-Kloc
RRRafał Rzepka
Rafał Rzepka
Background/Objectives: Teratomas of the sacrococcygeal region are rare, but the most common tumors found in fetuses. They develop from the three germ layers—mesoderm, ectoderm, and endoderm—and occur at a rate of 1 in 27,000 to 1 in 40,000, with a fourfold higher incidence in female fetuses. 63.9–74% of sacrococcygeal teratomas are detected prenatally, most often in the second trimester. Methods: This study reports the case of a woman in her second pregnancy at 29 weeks and 2 days gestation who was incidentally diagnosed with tumor-like lesion in the sacrococcygeal region of fetus. The clinical situation required the pregnancy to be delivered by emergency cesarean section, and the tumor was surgically removed within the first few days of life. The lesion was finally diagnosed as an immature teratoma, and appropriate management was initiated, resulting in stabilization of the child’s general condition and proper development. Results: Detailed imaging and characterization of the lesion are essential for determining the appropriate management and minimizing foreseeable obstetric and neonatal complications. Fetal echocardiography in cases of suspected teratoma in the sacrococcygeal region is essential for identifying life-threatening risk factors and influences the planning of further management. The choice of treatment depends on the clinical situation; among intrauterine interventions and pharmacological therapy, it has been demonstrated that surgical removal of the lesion within the first days of life reduces the risk of recurrence. Conclusions: In any case where lesion such as tumor of the sacrococcygeal region of fetus is suspected, the pregnant woman should be managed at a tertiary care center to ensure multidisciplinary care involving obstetricians, neonatologists, pediatric surgeons, and oncologists. This study provides a review of the literature on methods of diagnosis and treatment of sacrococcygeal teratomas in fetuses. It emphasizes the importance of accurate diagnosis and prenatal care in such cases and their impact on further management.

30 October 2026 in Cancers
Verified
Journal Article
Open access
PDF file
KKKamila Krejczy
Kamila Krejczy
JRJakub Rafał Rzepka
Jakub Rafał Rzepka
OWOlga Wiśniewska
Olga Wiśniewska
KMKaja Michalczyk
Kaja Michalczyk
ACAnita Chudecka-Głaz
Anita Chudecka-Głaz
RRRafał Rzepka
Rafał Rzepka
Background/Objectives: The differentiation of endometrial cancer from non-malignant endometrial findings remains clinically important. We evaluated serum human epididymis protein 4 (HE4), clinical and ultrasound features, and two published diagnostic models, the Risk of Endometrial Malignancy (REM) score and Model A. Methods: In this prospective cohort, 110 women with abnormal uterine bleeding and/or ultrasound abnormalities underwent HE4 testing, transvaginal ultrasonography, and hysteroscopy with histopathological assessment. Original univariable analyses were supplemented by reanalysis of the individual study records, including ROC metrics, paired comparisons of AUCs, and an exploratory logistic model adjusting for age and endometrial thickness. Results: Endometrial cancer was diagnosed in 18 women; 92 had non-malignant findings. Median HE4 was higher in the cancer group (118.35 versus 52.3 pmol/L; p < 0.001, as originally reported). The AUC (95% bootstrap CI) was 0.834 (0.686–0.951) for HE4, 0.905 (0.794–0.981) for REM, and 0.840 (0.702–0.948) for Model A. AUC differences were not statistically significant (paired DeLong tests, all p > 0.10). In an exploratory adjusted analysis, each doubling of HE4 was associated with higher odds of malignancy (adjusted OR 5.41; 95% CI 1.81–16.21; p = 0.0025). Conclusions: HE4 and both published models discriminated between malignant and non-malignant findings in this selected cohort. The findings are exploratory and require independent validation before clinical use.